INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 January 2011
Total net assets |
£100.8m |
NAV per share |
169.2p |
Share price |
148.5p |
Total value of unquoted investments |
£23.7m |
Total number of portfolio companies |
58 |
Cash |
0% NAV |
Cash committed and reserved to unquoted investments |
9% NAV |
Portfolio companies with < 1 year of cash |
12.9% NAV |
Top Ten Holdings
Company Name |
% NAV |
Shire Ltd |
5.58 |
Amgen |
5.31 |
Gilead Sciences |
4.87 |
Teva |
4.60 |
Celgene |
4.48 |
Micromet |
4.15 |
Insulet |
4.08 |
Cadent |
3.90 |
Biomarin |
2.90 |
Averion |
2.80 |
|
----------- |
Total |
42.67 |
Geographical Allocation |
% |
United States |
72 |
Europe |
26 |
Australia |
2 |
Cash |
0 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
76 |
Unquoted |
24 |
Cash |
0 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
17 FEBRUARY 2011